Diverse Mechanisms of Allergen Specific Immunotherapy
Journal: RUDN Journal of Medicine (Vol.23, No. 3)Publication Date: 2019-12-24
Authors : Lacin Cevhertas; Mübeccel Akdis;
Page : 233-249
Keywords : allergen immunotherapy (AIT); allergen; subcutaneous; sublingual; intralymphatic; epicutaneous; intradermal; oral; nasal; prognostic markers;
Abstract
Allergen immunotherapy (AIT) is widely used to establish a tolerant immune response and it is currently the only disease modifying treatment. There are different routes to administer the allergen, including subcutaneous, sublingual, intralymphatic, epicutaneous, intradermal, and oral and local nasal allergen immunotherapy. Although the optimal administration route depends on the type of allergen, some patients remain unresponsive and so it is important to predict the outcome before and during treatment. Therefore, there is a need to identify candidate prognostic markers for allergen immunotherapy. Herein, we discuss the recent literature on the molecular mechanisms of AIT.
Other Latest Articles
- Methods of Forming Humanistic Values in Students of Medical Universities in the Process of Learning a Discipline “Internal Diseases”
- Demographic characteristics of the Moscow region at the beginning of the XXI century
- Studying Possibilities of Using Beebread in Medicine with the Follow-Up Development of a Means to Improve Immunity
- Optimization of Therapy of Patient with Genetic Defect Antibody Production
- Morphology of GFAP-Positive Cells in Male and Female Rats’ Cerebral Cortex during the Cerebral Hypoxia Development according to the Stress Tolerance Level
Last modified: 2020-09-10 05:20:00